Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Lifestyle
Rebecca Whittaker

Weight-loss jabs could be given to children as young as six

  • New research suggests that weight-loss jabs, such as Wegovy and Mounjaro, could potentially benefit obese children as young as six.
  • Currently, these GLP-1 agonist medications are only recommended for adults on the NHS in England, despite being approved for adolescents in the US.
  • A US meta-analysis of 18 trials found the drugs significantly improved blood sugar control and weight in obese children and those with type 2 diabetes.
  • However, the study highlighted that gastrointestinal adverse events, including nausea and vomiting, were significantly more common among young people taking the drugs.
  • Experts are calling for longer follow-up periods and more real-world studies to establish the long-term effects of GLP-1 drugs in children and adolescents.

IN FULL

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.